cardiorisk 2017 - icom 2017 22nd ... ihab atia osama sanad sameh salama hazem khamis hany ragy amr...
TRANSCRIPT
www.cardio-risk.org
1
CardioRisk 2017 22nd – 23rd November 2017
The Egyptian Association of Vascular Biology and
Atherosclerosis شرايين القلب لتصلب الجمعية المصرية
Endorsed By
www.cardio-risk.org
2
Contents
Welcome Note
About EAVA & CardioRisk
EAVA Board
Internationa Guests Speakers
Organizational Notes
Audiovisual Instructions
Acknowledgement
Scientific Program
www.cardio-risk.org
3
On behalf of the Egyptian Association of Vascular biology & Atherosclerosis (EAVA) and
CardioRisk scientific board, Let me welcome you all in CardioRisk 2017 that will be held in
Hurghada Egypt 22-25 November 2017.
The meeting this year will not only cover lipidology science but, in addition, will extend to cover
many subjects related to CV risk factors especially hypertension and DM with eminent faculty.
Looking forward to seeing you all, and let me wish you an enjoyable and fruitful meeting.
Ashraf Reda, MD, FESC
President of EAVA
www.cardio-risk.org
4
CardioRisk CME activities started 2011, with a series of accredited educational meetings all over Egypt discussing assessment and management of cardiovascular risk in view of the different national and international guidelines.
The meeting this year will celebrate the fiundation of the familial hypercholesterolemia research forum (FHRF) in Egypt and the initiation of FH observational study in collaboration with the European Atherosclerosis Society
In addition to the cyclic CME activities, the annual congress and the ongoing Egyptian risk factor and lipid project, EAVA is initiating the CardioRisk research project including a national observational study and a promoting program supporting researches addressing cardiovascular risk and preventive strategies in the community.
CardioRisk 2017 scientific program will cover the recent updates in atherosclerosis, vascular biology and cardiovascular prevention by eminent speakers. CardioRisk scientific committee has the pleasure to invite you to participate and share with us the science of CardioRisk 2017 as well as the beauty of Hurghada, Egypt.
About EAVA & CardioRisk
www.cardio-risk.org
5
Founding President Ashraf Reda
Vice Presidents Atef Elbahry Nabil Farag
Secretary General Elsayed Farag
As. Secretary Ahmed Shawky Ahmed Elkersh
EAVA Board
Executive Board
Ihab Atia Osama Sanad Sameh Salama Hazem Khamis Hany Ragy Amr Kamal Tamer Moustafa Ahmed Boghdady
Office Board Ashraf Reda Ahmed Elkersh
Mourad Beshay Awny Gamal
www.cardio-risk.org
6
International Guests Speakers
Andreas Zirlik - Germany
Prof. Dr. Andreas Zirlik is Deputy Medical Director of the Department of Cardiology and Angiology I of the Heart Center of Freiburg University in Germany. He practices interventional cardiology and interventional hypertensiology and heads the heart failure and heart transplantation service. He also leads a research laboratory with a major interest in inflammatory mechanisms in atherogenesis and at the interface of cardiovascular, metabolic disease, and thrombosis.
Gerald Tomkin - Ireland Gerald Tomkin was born in Dublin Ireland and studied Medicine in Trinity College Dulin. He continued his post graduate trainijng in the UK and the USA before returning to take up a position as a consultant physician/Endocrinologist in the Adelaide and Meath Hospitals/Trinity College. His Research interests have focussed on diabetes, dyslipidaemiaand obesity. He is past vice president of the European Association for the study of diabetes, past president of Association of Physicians of Great Britain and Ireland and is currentlypresident of Diabetes Ireland.
www.cardio-risk.org
7
Michal Vrablik - Czech Republic Michal Vrablik M.D., Ph.D. is currently an Associate Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic. He is the chairman of the Czech Atherosclerosis Society, served as a member of the Executive Committee of the European Atherosclerosis Society between 2012 and 2016 and, also, a member of the board of the Czech Society of Internal Medicine and the board of the Working group of preventive cardiology of the Czech Society of Cardiology.
Stephan Von Haehling - UK Stephan Von Haehling is a consultant cardiologist and Associate Professor of Medicine at the Department of Cardiology and Pneumology at the University Medical Center Göttingen, Germany. He obtained his MD at the Institute of Immunology at Charité Medical School, Berlin, Germany. His PhD was awarded by Imperial College, London, UK after he completed studies into inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London. Dr. von Haehling has authored more than 200 original research papers, review articles, and editorials and serves on several editorial boards, including Journal of Cachexia, Sarcopenia and Muscle, ESC Heart Failure, International Journal of Cardiology, Clinical Science, Expert Opinion on Investigational Drugs and Archives of Medical Science. Dr von Haehling is Fellow of the European Society of Cardiology. His research interests include the pathophysiology of heart failure, muscle wasting, biomarkers, and novel treatments.
www.cardio-risk.org
9
Mövenpick Hurghada is located, nestled in Hurghada Bay, directly on its own beach and with private access to the Red
Sea. Only a ten-minute drive from Hurghada International Airport and a few minutes from the city center. The
Mövenpick Hurghada is nestled in Hurghada Bay, at the Southern end of town, directly on the famous promenade, a
pedestrian road, locally known as “the Mamsha”.
All rooms are on half Board Basis at
Movenpick Hotel
Hilton Hotel
Marriott Hotel
Grand Plaza Hotel
Lunch is only served upon coupons at Mövenpick Hotel
Conference Venue
Housing
www.cardio-risk.org
10
Registration desk will be ready on Wednesday 22nd of November at 14:30 Registration desk will be ready on Thursday, 23rd of November at 15:00 Registration desk will be ready on Friday, 24th of November at 15:30
All registrants and exhibitors must wear their name badge to have access to Conference sessions, lunches and social events. No exceptions will be made
www.Cardio-risk.org
Language The official language is English There will be no translation available
Weather Forecast
High: 35 / Low: 21
Electricity The electricity supply in Egypt is 220 Volts, 50 Hz. Most hotels also provide 110 Volts outlets for shavers
Currency Banking Rates are subjects to market fluctuations
Badge
Website
www.cardio-risk.org
11
Wednesday at 21:40
Thursday at 22:10
Friday at 22:00
All refreshments and Coffee Breaks activities will be served against coupon in the Conference kit. Each coupon is valid only for the meal mentioned on it and according to the timing mentioned below with no stop of the scientific program.
Coffee Breaks will be available at Exhibition Area
Coffee Breaks for Chairpersons and Speakers will be available at The Faculty Lounge
Dinner
www.cardio-risk.org
12
Audiovisual Instructions
Dear Speaker,
You will soon be presenting at CardioRisk Conference and we want
this experience to go as smoothly as possible for you. On behalf of
CardioRisk conference, ICOM will manage the audiovisual center and
provide you with assistance before, during and after your
presentation.
* Please make sure that you received your personal program (by e-
mail), we also advise that you check the final program available online.
* All speakers are required to submit their presentations at the
audiovisual center.
* Please make sure that you keep a copy of your presentation for
backup.
For Case Presentations
All case presentations should be submitted at least 24 hours prior to
the session Submitting your Presentation
• All presentations should be entirely in English.
•Microsoft Power Point, Apple Keynote and Prezi presentations are
supported.
• Please submit your presentation on Flash Memory or CD/DVD.
• Please make sure that the presentation contains all media and video
files included in your presentation.
• It’s not allowed to use your personal laptop.
• Presentations should be submitted to the audiovisual center at least
one hour before the start of your session to be able to prepare it.
Inside The Hall
• Please arrive at the Congress main hall at least 10 minutes prior to the
beginning of your session.
• Thank you for abiding by the allocated duration of your presentation.
• A computerized countdown timer will be displayed on screen and will
automatically close the presentation once the time is finished
www.cardio-risk.org
13
CardioRisk 2017 Expresses great gratitude to the following companies sharing in the activities and success of the conference
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Acknowledgement
www.cardio-risk.org
16
Wednesday 22nd November 2017
16:00 – 16:45 Session 1
Dialogue I - Obesity
16:50 – 17:20 Session 2
Debate I - Statin and Diabetes
17:25 – 18:25 Session 3
EAVA Rising Stars I - Case Dialogue
18:30 – 19:00 Session 4
Debate II - Dietary Fat a Friend or an Enemy ? 19:00 – 19:15 Coffee Break
19:15 – 20:05 Session 5
Dialogue II - Dealing With The Elderly
20:10 – 20:55 Session 6
Plenary I - The Issue of Hypertriglyceridemia
21:00 – 21:40 Sanofi Symposium
21:40 Dinner
At Glance
Grant from
Sanofi
www.cardio-risk.org
17
Hall: Main - 16:00 - 16:45
Session 1
Dialogue I Obesity
Commentators (in Alphabetical Order)
Ahmed El Ghalid - Suez Canal Amr Kamal - Alexandria Mohamed Abdelshafy – Banha Sharaf Ashazly - Sohag
Discussants (in Alphabetical Order)
El Sayed Farag – Zagazig Enas Shaltout - Cairo Gehan Fouad – Cairo
Moderator
Atef Elbahry - Port Said 16:00 - 16:10 Introductions and questions to the panellists: Obesity is a chronic disease
Atef Elbahry Port Said
16:10 - 16:15 Answer Q1: Barriers in clinical practice facing obesity
Enas Shaltout Cairo 16:15 - 16:20 Discussion
16:20 - 16:25 Answer Q2: The obesity paradox
El Sayed Farag Zagazig 16:25 - 16:30 Discussion
16:30 - 16:40 Answer Q4: Nutritional aspects
Gehan Fouad Cairo 16:40 - 16:45 Discussion
www.cardio-risk.org
18
Hall: Main - 16:50 - 17:20
Session 2
Debate I Statin and Diabetes
Chairpersons (in Alphabetical Order)
Ahmed El Kersh - Menoufia El Sayed Abdel Khalek - Banha Mahmoud Soliman - Menoufia Tarek Naguib - Zagazig
16:50 - 17:02 Statin and Diabetes
Pro Mohamed Seleem NHI
17:02 - 17:14 Contra
Ahmed Shawky Ain Shams
17:14 - 17:20 Discussion
www.cardio-risk.org
19
Hall: Main - 17:25 - 18:25
Session 3
EAVA Rising Stars I Case Dialogue
Discussants (in Alphabetical Order)
Ahmad Boghday - Sohag Ahmed El Zaiaat - Zagazig Ashraf Reda - Menoufia Mohamed Seleem - NHI
Moderator
El Sayed Farag - Zagazig 17:25 - 17:35 2ry Hypertension case
Zagazig Team Ahmed Eraky Zagazig Ayman Naguib Zagazig
17:35 - 17:45 Comments and discussion
17:45 - 17:55 Familial Dyslipidemia
Ain Shams Team Amr Gamal Shawky Ain Shams Shehab El Etriby Ain Shams
17:55 - 18:05 Comments and discussion
18:05 - 18:15 Diabetic nephropathy
Alexandria Team
Ahmed Yehia Alexandria Ashraf Elamin Alexandria
18:15 - 18:25 Comments and discussion
www.cardio-risk.org
20
Hall: Main - 18:30 - 19:00
Session 4
Debate II Dietary Fat a Friend or an Enemy ?
Chairpersons (in Alphabetical Order)
Hazem Khamis - Six October Mahmoud Kamel - Menoufia Morad Beshay - Menoufia
Moderator
Ihab Attia - Ain Shams 18:30 - 18:42 Does dietary Fat increase CV risk?
NO Nabil Farag Ain Shams
18:42 - 18:54 YES
Ashraf Reda Menoufia 18:54 - 19:00 Discussion
Coffee Break
19:00 – 19:15
www.cardio-risk.org
21
Hall: Main - 19:15 - 20:05
Session 5
Dialogue II Dealing With The Elderly
Commentators (in Alphabetical Order)
Awny Gamal – Menoufia El Sayed Farag - Zagazig Nabil Farag - Ain Shams
Discussants (in Alphabetical Order)
Amr Kamal - Alexandria Enas Shaltout - Cairo Ihab Attia - Ain Shams Tamer Moustafa - Zagazig
Moderator
Hazem Khamis - Six October 19:15 - 19:25 Introductions and questions to the panellists
Hazem Khamis Six October
19:25 - 19:30 Answer Q1: The elderly with hypertension
Tamer Moustafa Zagazig 19:30 - 19:35 Discussion
19:35 - 19:40 Answer Q2: The elderly with diabetes
Enas Shaltout Cairo
19:40 - 19:45 Discussion
19:45 - 19:50 Answer Q3: The elderly with Dyslipidemia
Ihab Attia Ain Shams 19:50 - 19:55 Discussion
19:55 - 20:00 Answer Q4: The elderly with ACS
Amr Kamal Alexandria 20:00 - 20:05 Discussion
www.cardio-risk.org
22
Hall: Main - 20:10 - 20:55
Session 6
Plenary I The Issue of Hypertriglyceridemia
Chairpersons (in Alphabetical Order)
Ahmad Boghday – Sohag Ihab Attia - Ain Shams Nevine Samy – Menoufia Walid Abdou - Menoufia
Moderator
Ashraf Reda - Menoufia 20:10 - 20:22 Metabolic pathway
Ahmed Shawky Ain Shams 20:22 - 20:25 Discussion
20:25 - 20:37 Relation to CV events
Hassan Khaled Cairo 20:37 - 20:40 Discussion
20:40 - 20:52 Treatment algorithm
Tamer Moustafa Zagazig 20:52 - 20:55 Discussion
www.cardio-risk.org
23
Hall: Main - 21:00 - 21:40
Sanofi Symposium
Chairpersons (in Alphabetical Order)
Ahmed Fathy - NHI Ashraf Reda - Menoufia Ihab Attia - Ain Shams Nabil Farag - Ain Shams
21:00 - 21:15 Comprehensive Cardiovascular Protection Beyond BP Control
Waleed ElAwady Zagazig 21:15 - 21:20 Discussion
21:20 - 21:35 ACS and beyond: Role of antiplatelets in polyvascular patient
Tamer Moustafa Zagazig 21:35 - 21:40 Discussion and Closing Remarks
Day 1 Group Photo
Dinner 21:40
www.cardio-risk.org
24
Thursday 23rd November 2017
12:00 – 15:00 Cath Competition
Bifurcation, Complex PCI and others
16:00 – 17:00 Session 7
Diabetes I - Is Cardiovascular Protection at Long Last a Reality?
17:05 – 17:50 Session 8
Dialogue III - Genetic Studies and CV Protection
17:55 – 18:55
Session 9
Joint Session Between the Egyptian (EAVA) and German (DGAF) Atherosclerosis Societies The Future of Cardiovascular Risk Management – Targeting Inflammation or Targeting Lipid
18:15 - 18:45 Coffee Break
19:00 – 19:45 Novartis Symposium
Heart Failure 2017
19:50 – 20:40 Session 10
Planery II - The Guidelines: What Happened?
20:45 – 21:35 Session 11
Game Changing Trials I
21:40 – 22:10 Sanofi Symposium
22:10 Dinner
At Glance
www.cardio-risk.org
25
Hall: Main - 12:00 - 15:00
Cath Competition
Bifurcation, Complex PCI and others Moderators (in Alphabetical Order)
Adel El Etriby - Ain Shams Amr El Hadidy - Cairo Hamdy Soliman - NHI M Fareed Elguindy - NHI Nabil Farag - Ain Shams
www.cardio-risk.org
26
Hall: Main - 16:00 - 17:00
Session 7
Diabetes I Is Cardiovascular Protection at Long Last a Reality?
Chairpersons (in Alphabetical Order)
Adel El Etriby - Ain Shams Alaa Medhat - Cairo Enas Shaltout – Cairo Hesham Rashid - Banha Noshy Youssef - Ain Shams Tarek Zaky - Ain Shams
Moderator
Atef Elbahry - Port Said 16:00 - 16:10 The cardiologist review
Atef Elbahry Port Said 16:10 - 16:13 Discussion
16:13 - 16:23 Update in hypertension management in the diabetic
El Sayed Farag Zagazig 16:23 - 16:26 Discussion
16:26 - 16:40 Update in lipid management in the diabetic
Mohamed Abdelghany Cairo
16:40 - 16:45 Discussion
16:45 - 17:00 Diabetes, Dyslipidemia and atherosclerosis
Gerald Tomkin Ireland
www.cardio-risk.org
27
Hall: Main - 17:05 - 17:50
Session 8
Dialogue III Genetic Studies and CV Protection
Commentators (in Alphabetical Order)
Gamal Shaaban – NHI Ghada Kazamel - NHI Hany Ragy – NHI Khairy Abdel Dayem - Ain Shams Khaled Leon – NHI Ragab Abdelsalam - Zagazig
Discussants (in Alphabetical Order)
Ahmed Shawky - Ain Shams Amal Rizk - Cairo Ihab Attia - Ain Shams Karim Mahmoud Abdel Hamid - Cairo
Moderator
Ashraf Reda - Menoufia 17:05 - 17:10 Introduction and questions
Ashraf Reda Menoufia 17:10 - 17:15 Answer Q1: The earlier the better
Ihab Attia Ain Shams 17:15 - 17:20 Discussion
17:20 - 17:25 Answer Q2: Diagnosis of Familial hypercholesterolemia
Ahmed Shawky Ain Shams 17:25 - 17:30 Discussion
17:30 - 17:35 Answer Q3: Value of Mandelian randomisation studies
Karim Mahmoud Abdel Hamid Cairo
17:35 - 17:40 Discussion
17:40 - 17:45 Answer Q 4: Genetic screening for whom
Amal Rizk Cairo 17:45 - 17:50 Discussion
www.cardio-risk.org
28
Hall: Main - 17:55 - 18:55
Session 9
Joint Session Between the Egyptian (EAVA) and German (DGAF) Atherosclerosis Societies The Future of Cardiovascular Risk Management – Targeting Inflammation or Targeting Lipid
Chairpersons (in Alphabetical Order)
Ahmed Shawky - Ain Shams El Sayed Farag - Zagazig Hazem Khamis - Six October Nabil Farag - Ain Shams Ossama Sanad - Banha
17:55 - 18:07 Anti-inflammatory therapy of Atherosclerosis - CANTOS from hope to reality
Andreas Zirlik Germany 18:07 - 18:10 Discussion
18:10 - 18:22 LDL cholesterol - Far more than a simple risk factor
Ashraf Reda Menoufia 18:22 - 18:25 Discussion
18:25 - 18:37 Modern lipid management in the era of PCSK9 inhibition - How low should we go ?
Atef Elbahry Port Said 18:37 - 18:40 Discussion
18:40 - 18:52 Balancing residual inflammatory and residual risk: An outlook
Andreas Zirlik Germany 18:52 - 18:55 Discussion
Group photo for the first German/ Egyptian Atherosclerosis CME activity
Coffee Break 18:15 – 18:45
www.cardio-risk.org
29
Hall: Main - 19:00 - 19:45
Novartis Symposium
Heart Failure 2017 Chairpersons (in Alphabetical Order)
Alaa Etman - NHI Diaa El Menshawy - zagazig Hossam Kandil - Cairo Khalid Shokry - Military Academy Magdy Abdel Hamid - Cairo
19:00 - 19:12 ARNi & Guidelines of heart failure
Ashraf Reda Menoufia 19:12 - 19:15 Discussion
19:15 - 19:27 Quality of life in heart failure does ARNi change it
Atef Elbahry Port Said 19:27 - 19:30 Discussion
19:30 - 19:42 Heart Failure & hospitalization
Sameh Emil Military Academy 19:42 - 19:45 Discussion
www.cardio-risk.org
30
Hall: Main - 19:50 - 20:40
Session 10
Planery II The Guidelines: What Happened?
Chairpersons (in Alphabetical Order)
Amin Fouad - Military Academy Amr El Hadidy - Cairo Ayman Aboul Magd - Al Azhar Mohamed Sobhy - Alexandria Sameh Emil - Military Academy
19:50 - 20:02 STEMI guidelines
Hesham Salah El Din Cairo 20:02 - 20:05 Discussion
20:05 - 20:20 Recent development of HF 2016 guidelines
Stephan Von Haehling Germany 20:20 - 20:25 Discussion
20:25 - 20:37 P2y12 inhibitors guidelines in ACS +AF – Dual or triple
Mohamed Seleem NHI 20:37 - 20:40 Discussion
www.cardio-risk.org
31
Hall: Main - 20:45 - 21:35
Session 11
Game Changing Trials I Chairpersons (in Alphabetical Order)
Ahmed Magdy – NHI Alaa Elghamrawy - El Mahala Hesham Aboul Einen – Banha Ramzy Elmawardy - Ain Shams Tarek Abdel Ghaffar – NHI
Moderator
Tamer Moustafa - Zagazig 20:45 - 20:57 EMPA-REG OUTCOME
Ihab Attia Ain Shams 20:57 - 21:00 Discussion
21:00 - 21:15 The REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid modification) Andreas Zirlik Germany
21:15 - 21:20 Discussion
21:20 - 21:32 PARADIGM HF trial
Magdy Abdel Hamid Cairo 21:32 - 21:35 Discussion
www.cardio-risk.org
32
Hall: Main - 21:40 - 22:10
Sanofi Symposium
Chairpersons (in Alphabetical Order)
Abdulla Moustafa - Menoufia Aly Saad - Zagazig Amr El Hadidy - Cairo Ezz El Din El Sawy - Al Azhar Fayez Fayek - NHI Gamal Fahim - Mansoura Magdy Mattar - Alexandria
21:40 - 22:00 Current status and future prospect in dyslipidaemia management
Ashraf Reda Menoufia 22:00 - 22:10 Discussion
Day 2 Group Photo
Dinner 22:10
www.cardio-risk.org
33
Thursday 23rd November 2017
15:30 – 16:15 Session 12
EAVA Rising Stars II
16:30 – 17:15
Session 13
Dialogue Room IV - Hypertension – Masked, White Coat or Something Else? Hypertension Issues
17:25 – 18:05 Session 14
Plenary III - The CV Continuum and Novel Therapeutics
18:10 – 18:40 AstraZeneca Symposium
18:45 – 19:15 Coffee Break
18:45 – 19:45 Session 15
Plenary IV - Questions in Dyslipidaemia Management
19:50 – 20:40 Session 16
Game Changing Trials II
20:40 – 21:10 Servier Symposium
21:10 – 22:05 Session 17
Plenery V - Smoking in Egypt : What To Do? 22:05 Dinner
At Glance
www.cardio-risk.org
34
Hall: Main - 15:30 - 16:15
Session 12
EAVA Rising Stars II Discussants (in Alphabetical Order)
Ahmed Shawky - Ain Shams Karim Mahmoud Abdel Hamid - Cairo Mohamed Abdelshafy - Banha Moustafa Mokarab - Al Azhar Sharaf Ashazly - Sohag Waleed Ammar - Cairo Yasser Huzayen - Ain Shams
Moderator
El Sayed Farag - Zagazig
EAVA mini quiz (Education by Competition)
www.cardio-risk.org
35
Hall: Main - 16:30 - 17:15
Session 13
Dialogue Room IV Hypertension – Masked, White Coat or Something Else?
Hypertension Issues Commentators (in Alphabetical Order)
Ahmed Abdellatif Ramadan - Al Azhar Aly Kasem - Sohag Khaled El Rabbat – Banha Moustafa Elsayed - Al Azhar Saeid Shalaby – Menoufia Yasser Abdelhady -
Discussants (in Alphabetical Order)
Amr El Hadidy - Cairo Hossam Kandil - Cairo Ramzy Elmawardy - Ain Shams
Moderator
Ashraf Reda - Menoufia 16:30 - 16:40 Introduction and questions
Ashraf Reda Menoufia 16:40 - 16:45 Answer to Q1 - White coat hypertension , is it really matter?
Ramzy Elmawardy Ain Shams 16:45 - 16:50 Discussion
16:50 - 17:00 Answer Q2: Dipper/ non-dipper and CV risk
Amr El Hadidy Cairo 17:00 - 17:05 Discussion
17:05 - 17:10 Answer Q3: Masked hypertension
Hossam Kandil Cairo 17:10 - 17:15 Discussion
www.cardio-risk.org
36
Hall: Main - 17:25 - 18:05
Session 14
Plenary III The CV Continuum and Novel Therapeutics
Chairpersons (in Alphabetical Order)
Ahmed Wafa - Mansoura Ayman Aboul Magd - Al Azhar Ihab Attia - Ain Shams Mohamed Sobhy - Alexandria Ossama Sanad - Banha
17:25 - 17:40 Risk stratification 2017 and high CV risk identification
Michal Vrablik Czech Republic 17:40 - 17:45 Discussion
17:45 - 18:00 New drugs in HF - From omecamtive mecorbil to vericiguard
Stephan Von Haehling Germany 18:00 - 18:05 Discussion
www.cardio-risk.org
37
Hall: Main - 18:10 - 18:40
AstraZeneca Symposium
Chairpersons (in Alphabetical Order)
Ahmed Yehia Hegab - NHI Amr El Hadidy - Cairo Magdy El Khadem - NHI Mahmoud Hassanein - Alexandria Sherif Wagdy Ayad - Alexandria Yehia Kishk - Assiut
18:10 - 18:22 Fresh look on DAPT choice and duration
Ramez Guindy Ain Shams
18:22 - 18:25 Discussion
18:25 - 18:37 Role of Seloken ZOC in Hypertension and Heart disease
Ashraf Reda Menoufia
18:37 - 18:40 Discussion
www.cardio-risk.org
38
Hall: Main - 18:45 - 19:45
Session 15
Plenary IV Questions in Dyslipidaemia Management
Chairpersons (in Alphabetical Order)
Adel Alam - Al Azhar Ahmed Fathy - NHI Ezz El Din El Sawy - Al Azhar Islam Shawki - Al Azhar Mohamed Gamal - Assiut Samia Elkady - NHI
18:45 - 18:57 LDL cholesterol goal 70 mg/dl? 50 mg/dl? or even less?
Nabil Farag Ain Shams 18:57 - 19:00 Discussion
19:00 - 19:12 Mandelian Randomisation studies and LDL causality
Ahmed Shawky Ain Shams 19:12 - 19:15 Discussion
19:15 - 19:27 New therapies in dyslipidemia management Michal Vrablik Czech Republic
19:27 - 19:30 Discussion
19:30 - 19:42 Bile, lipid and glucose metabolism between weight reduction and bariatric surgery
Gerald Tomkin Ireland 19:42 - 19:45 Discussion
Coffee Break 19:00 – 19:30
www.cardio-risk.org
39
Hall: Main - 19:50 - 20:40
Session 16
Game Changing Trials II Chairpersons (in Alphabetical Order)
Esam Mahfouz - Mansoura Gamila Mohamed Nasr - Suez Canal Ihab Daoud Hanna - MOH Ikram Sadek - Tanta Ramez Guindy - Ain Shams Waleed ElAwady - Zagazig
Moderator
Tamer Moustafa - Zagazig 19:50 - 20:02 COMPASS
Hany Ragy NHI 20:02 - 20:05 Discussion
20:05 - 20:17 ORBITA
Mohammed Hassan Cairo 20:17 - 20:20 Discussion
20:20 - 20:35 IMPROVE-IT changes the guidlines
Atef Elbahry Port Said 20:35 - 20:40 Discussion
www.cardio-risk.org
40
Hall: Main - 20:40 - 21:10
Servier Symposium
Chairpersons (in Alphabetical Order)
Ashraf Reda - Menoufia Sameh Emil - Military Academy Samir Rafla - Alexandria
20:40 - 20:52 Use of long acting treatment in hypertension management
Ramez Guindy Ain Shams 20:52 - 20:55 Discussion
20:55 - 21:07 Listening to ischemic heart needs
Amin Fouad Military Academy 21:07 - 21:10 Discussion
www.cardio-risk.org
41
Hall: Main - 21:10 - 22:05
Session 17
Plenery V Smoking in Egypt : What To Do?
Chairpersons (in Alphabetical Order)
Mesbah Taha Hassanein – Zagazig Mona Aboul Seoud - Ain Shams Nasser Taha – Minia Tarek El Khouly - Cairo William Moris -
Moderator
Atef Elbahry - Port Said 21:10 - 21:20 Smoking - The CV burden
Atef Elbahry Port Said 21:20 - 21:23 Discussion
21:23 - 21:33 Smoking in Egyptians with ACS - Data from CardioRisk project Ashraf Reda Menoufia
21:33 - 21:36 Discussion
21:36 - 21:46 What to do
Hany Ragy NHI
21:46 - 21:49 Discussion
21:49 - 21:59 Smoking in the guidelines
Ihab Attia Ain Shams 21:59 - 22:05 Discussion
Day 3 Group Photo
Dinner 22:05